Wednesday, February 22, 2017 - 15:10
With the advent of CRISPR technology, editing human genomes is no longer the stuff of science fiction. But Hank Greely, a Stanford law professor and bioethicist, isn’t too concerned: “I don’t think it’s very important, I don’t think it’s gonna happen, but I don’t care about it even if it does,” he remarked (perhaps with a bit of tongue in his cheek), speaking at UCSF in January.